Insulet | PODD - Debt




Insulet reported $1.4B in Debt for its fiscal quarter ending in September of 2024.

Debt Change Date
Abbott USD 14.98B 225M Sep/2024
Align Technology USD 0 129.09M Sep/2024
AtriCure USD 61.86M 0 Dec/2024
Avanos Medical USD 202.2M 16.1M Sep/2024
Baxter International USD 12.94B 408M Sep/2024
Becton, Dickinson and Co. USD 18.76B 1.35B Dec/2024
Boston Scientific USD 10.89B 51M Sep/2024
Cardinal Health USD 7.61B 2.44B Dec/2024
Cooper Companies USD 2.58B 48.7M Oct/2024
Dexcom USD 2.44B 149.8M Dec/2024
Edwards Lifesciences USD 706.7M 13.7M Sep/2024
Eli Lilly USD 31.12B 2.23B Sep/2024
Globus Medical USD 443.35M 4.46M Dec/2024
ICU Medical USD 1.6B 80.69M Sep/2024
Insulet USD 1.4B 500K Sep/2024
Integra LifeSciences USD 1.81B 202.87M Sep/2024
J&J USD 35.75B 5.74B Sep/2024
Masimo USD 733.2M 130.2M Sep/2024
Medtronic USD 26.61B 1.72B Jan/2025
Merit Medical Systems USD 750.5M 120.6M Sep/2024
Roche Holding CHF 34.44B 5.23B Jun/2024
Solventum Corp 8.11B 197M Sep/2024
Stryker USD 12.19B 1.14B Dec/2024
Tandem Diabetes Care USD 348.43M 128.68M Sep/2024
Teleflex USD 1.76B 62.12M Sep/2024
West Pharmaceutical Services USD 202.6M 102.2M Dec/2024
Zimmer Biomet Holdings USD 6.2B 246.1M Dec/2024